F. Hoffmann-La Roche sees highest filings and grants during August in Q3 2023

F. Hoffmann-La Roche has been focused on protecting inventions in United States(US) with 333 publications in Q3 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 19% filings and 23% grants. The United States(US), European Patent Office (E/P), China(CN), and Japan(JP) patent Office are among the top ten patent offices where F. Hoffmann-La Roche is filings its patents. Among the top granted patent authorities, F. Hoffmann-La Roche has 23% of its grants in United States(US), 23% in European Patent Office (E/P), and 11% in China(CN).

Amgen could be the strongest competitor for F. Hoffmann-La Roche

In terms of grant share, F. Hoffmann-La Roche stands in one position among its competitors. Amgen and johnson & johnson secured the top positions according to recent patent publication data.

Patents related to healthtech and rare diseases lead F. Hoffmann-La Roche’s portfolio

F. Hoffmann-La Roche has the highest number of patents in healthtech followed by, rare diseases and climate change. For healthtech, nearly 20% of patents were filed and 16% of patents were granted in Q3 2023.

Healthcare it related patents lead F. Hoffmann-La Roche portfolio followed by image management, and breast cancer

F. Hoffmann-La Roche has highest number of patents in healthcare it followed by image management, breast cancer, medical device and drug delivery devices. For healthcare it, nearly 5% of patents were filed and 2% of patents were granted in Q3 2023.

For comprehensive analysis of F. Hoffmann-La Roche’s filings and grants, buy the databook here.

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.